Emma Natasha Walmsley, HonFRSC (born June 1969)[1] is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty, who retired in March 2017.[2]
Walmsley was born in June 1969 in Barrow-in-Furness in Lancashire (now Cumbria), the daughter of Vice-Admiral Sir Robert Walmsley[3] and Lady Christina Walmsley (born Christina V Melvill).[4] She boarded at St Swithun's School, Winchester,[3] and has a master's degree in Classics and Modern Languages from Oxford University.[5][6]
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company which has its headquarters in Brentford, London. The company was established in 2000 by the merger of Glaxo Wellcome (formed from the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc (formed from the merger of Beecham plc and SmithKline Beckman Corporation, which in turn was formed by combining the Smith Kline French and Beckman companies).
